At a Glance
| 3,4-CTMP | 2-Aminoindane | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (oral) | 4–6 mg | 10–20 mg |
| Total Duration | 1–2 hrs | 0.2–0.5 hrs |
| Routes | oral | oral |
| Effects | 44 documented | 27 documented |
3,4-CTMP, a Stimulants, and 2-Aminoindane, a Stimulants, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Stimulantss, meaning they share a common pharmacological foundation. They share 21 documented effects in common, with 23 effects unique to 3,4-CTMP and 6 unique to 2-Aminoindane. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| 3,4-CTMP | 2-Aminoindane | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (oral) | 4–6 mg | 10–20 mg |
| Total Duration | 1–2 hrs | 0.2–0.5 hrs |
| Routes | oral | oral |
| Effects | 44 documented | 27 documented |
| Level | 3,4-CTMP | 2-Aminoindane |
|---|---|---|
| Threshold | 2 mg | 3 mg |
| Light | 2–4 mg | 5–10 mg |
| Common | 4–6 mg | 10–20 mg |
| Strong | 6–8 mg | 20–40 mg |
| Heavy | 8 mg | 40 mg |
3,4-CTMP
2-Aminoindane
No direct interaction data available between these substances. This does not mean the combination is safe.